2-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid, 95.0%, 25g

2-Chloroacrylonitrile (stabilized with HQ)>99.0%(GC)500mL

2-(2-Fluoro-4-(methylsulfonyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95+%, 1g

6-Chloro-1H-pyrrolo[2,3-b]pyridin-2(3H)-one, 95.0%, 10g

3-(7-Cyano-5-(2-nitropropyl)indolin-1-yl)propyl benzoate, 95.0%, 5g

Sodium 2-oxobutanoate, 95.0%, 1g

3,5-Dichloro-2'-methylbenzophenone, 97.0%, 1g

5-Bromo-6-fluoro-2-methyl-2h-indazole, 97%, 1g

3-Methylpyrimidine-2,4(1H,3H)-dione, 95.0%, 2.5g

HARPAGOSIDE, 97%, 100mg

2-Methyl-N-phenylaniline, 98.0%, 10g

4,4',4''-(Ethane-1,1,1-triyl)triphenol, 95.0%, 500g

3-Bromo-5-methyl-2-pyridone>98.0%(GC)(T)5g